1.
Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib
by Dadu, Ramona
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (6), p.2086-2094

2.
Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience
by Dadu, Ramona
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (1), p.E77-E81
